Gadoversetamide

Gadoversetamide

Clinical data
AHFS/Drugs.com	Micromedex Detailed Consumer Information
Pregnancy cat.	C(US)
Legal status	?
Routes	Intravenous
Pharmacokinetic data
Protein binding	Nil
Metabolism	Nil
Half-life	80 to 120 minutes
Excretion	Renal
Identifiers
CAS number	131069-91-5 Y
ATC code	V08CA06
PubChem	CID 6435809
DrugBank	APRD00993
ChemSpider	392041 Y
UNII	RLM74T3Z9D Y
KEGG	D01646 Y
ChEMBL	CHEMBL1200457 N
Chemical data
Formula	C20H34GdN5O10
Mol. mass	661.77 g/mol
SMILES	eMolecules & PubChem
InChI InChI=1S/C20H37N5O10.Gd/c1-34-9-3-21-16(26)11-24(14-19(30)31)7-5-23(13-18(28)29)6-8-25(15-20(32)33)12-17(27)22-4-10-35-2;/h3-15H2,1-2H3,(H,21,26)(H,22,27)(H,28,29)(H,30,31)(H,32,33);/q;+3/p-3 Y Key:HBEAOBRDTOXWRZ-UHFFFAOYSA-K Y
N(what is this?)  (verify)

Gadoversetamide is a gadolinium-based MRI contrast agent, particularly for imaging of the brain, spine and liver.^[1] It is marketed under the trade name OptiMARK.

Notes

1. ^ "Gadoversetamide Drug Information". Drugs.com. 2000-03-20. http://www.drugs.com/MMX/Gadoversetamide.html. Retrieved 2007-03-23. 

Iodinated,
Water insoluble

Ethyl esters of iodised fatty acids • Iopydol • Propyliodone • Iofendylate • Lipiodol

Non-iodinated

Barium sulfate^#

MRI

Paramagnetic	Gadolinium-based: Gadobenic acid • Gadobutrol • Gadodiamide • Gadofosveset • Gadolinium • Gadopentetic acid • Gadoteric acid • Gadoteridol • Gadoversetamide • Gadoxetic acid Other: Ferric ammonium citrate • Mangafodipir
Superparamagnetic	Ferumoxsil • Ferristene • Iron oxide, nanoparticles
Other	Perflubron

Ultrasound

Microspheres of human albumin • Microparticles of galactose • Perflenapent • Microspheres of phospholipids • Sulfur hexafluoride

^#WHO-EM. ^‡Withdrawn from market. Clinical trials: ^†Phase III. ^§Never to phase III